Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771173 · ClinicalTrials.gov registry record · Phase 4
CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial
A Phase 4 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 4
- Development phase
- 258
- Enrollment target
NCT00771173 is a Phase 4 study that has completed, run by Loyola University. The registered enrollment target is 258 participants.
The verdict
NCT00771173, a Phase 4 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 258 participants
- Enrollment target
Study Summary
The primary aim of this randomized clinical trial is to compare the utility of phenazopyridine HCl vs. placebo in reducing catheter-associated discomfort during the post-operative period in the gynecologic patient using mean VAS measurments.
Interventions
- OTHER Placebo
- DRUG phenazopyridine HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771173
The ClinicalTrials.gov registry entry for NCT00771173 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00771173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771173 about?
NCT00771173 is a clinical study titled "CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial". The primary aim of this randomized clinical trial is to compare the utility of phenazopyridine HCl vs. placebo in reducing catheter-associated discomfort during the post-operative period in the gynecologic patient using mean VAS measurments.
What is the current status of trial NCT00771173?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 258 participants. The study started on 2008-08. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00771173?
The interventions under investigation include: Placebo (OTHER), phenazopyridine HCl (DRUG).
Who is sponsoring clinical trial NCT00771173?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.